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ABSTRACT
Active positive transcription elongation factor b
(P-TEFb) is essential for cellular and human im-
munodeficiency virus type 1 (HIV-1) transcription
elongation. CTIP2 represses P-TEFb activity in
a complex containing 7SK RNA and HEXIM1.
Recently, the inactive 7SK/P-TEFb small nuclear
RNP (snRNP) has been detected at the HIV-1 core
promoter as well as at the promoters of cellular
genes, but a recruiting mechanism still remains
unknown to date. Here we show global synergy
between CTIP2 and the 7SK-binding chromatin
master-regulator HMGA1 in terms of P-TEFb–
dependent endogenous and HIV-1 gene expression
regulation. While CTIP2 and HMGA1 concordingly
repress the expression of cellular 7SK-dependent
P-TEFb targets, the simultaneous knock-down of
CTIP2 and HMGA1 also results in a boost in Tat-de-
pendent and independent HIV-1 promoter activity.
Chromatin immunoprecipitation experiments reveal
a significant loss of CTIP2/7SK/P-TEFb snRNP re-
cruitment to cellular gene promoters and the HIV-1
promoter on HMGA1 knock-down. Our findings not
only provide insights into a recruiting mechanism
for the inactive 7SK/P-TEFb snRNP, but may also
contribute to a better understanding of viral latency.
INTRODUCTION
In eukaryotic cells, RNA Polymerase II (RNA Pol II) is
responsible for the transcription of protein-coding genes.
On promoter clearance, the enzyme is paused in a
promoter proximal position by the negative elongation
factor and the 5,6-Dichloro-1-beta-D-ribofuranosylben-
zimidazole (DRB) sensitivity-inducing factor (DSIF),
which poises RNA Pol II to promptly react to upstream
signals and generate full-length mRNA transcripts (1,2).
The positive transcription elongation factor b (P-TEFb) is
important to overcome this transcriptional block, as active
P-TEFb, consisting of the Cyclin-dependent kinase 9 (Cdk9)
as well as one of the Cyclins T1 (CycT1) or T2, phosphor-
ylates negative elongation factor and DSIF as well as the
carboxy-terminal domain of the paused polymerase, result-
ing in efﬁcient transcriptional elongation (1–3). P-TEFb
activity is negatively controlled in a ribonucleo-protein
complex (RNP) containing the 7SK non-coding RNA and
the Hexamethylene bis-acetamide inducible 1 (HEXIM1)
protein (4,5). MePCE and LARP7 bind to the 50- and the 30-
end of 7SK RNA, that way contributing to the maintenance
of the integrity of this 7SK RNP (6,7). Besides the expres-
sion of cellular genes, also the expression of human im-
munodeﬁciency virus type 1 (HIV-1) essentially depends
on P-TEFb, making HIV-1 a model system for studying
P-TEFb function. Here, the viral transactivator of transcrip-
tion (Tat) targets the inactive 7SK/P-TEFb RNP, displacing
7SK RNA and HEXIM1 to ensure efﬁcient viral
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transcription (8,9). The 7SK/P-TEFb small nuclear RNP
(snRNP) has recently been detected at the HIV-1 core
promoter in a Sp1-dependent manner (8), where the Tat-
recruited transcription factors PPM1G/PP2Cg activate P-
TEFb by mediating its release from the 7SK RNP (10),
but a mechanism for 7SK RNP recruitment remains
elusive to date.
In a recent study, we have identiﬁed the chicken ovalbu-
min upstream promoter transcription factor (COUP-TF)
interacting protein 2 (CTIP2) as a novel compound of the
7SK/HEXIM1/P-TEFb snRNP, efﬁciently contributing
to P-TEFb inactivation (11). CTIP2 is expressed in micro-
glial cells, the resident macrophages of the central nervous
system, which are the primary targets of productive HIV-1
infection within the brain (12). Moreover, high levels of
CTIP2 expression inmicroglial cells from infected patients
are correlated with HIV-1 post-integration latency (13).
Besides the well-studiedHIV-1–infected CD4+T-lympho-
cytes they are considered as the major reservoir of latent
virus (14). CTIP2 is an important factor for T-lymphocyte
as well as spinal cord development (15,16) and has been
shown to repress transcription of the integrated HIV-1
genome in microglial cells by several ways and thus
might be a key factor for establishing and/or maintaining
viral latency. In addition to its role as a negative regulator
of P-TEFb,CTIP2 is able to repressHIV-1 gene expression
by delocalizing Tat to the heterochromatin-associated
protein HP1 (17). Furthermore, it can repress the initial
phase of HIV-1 transcription by direct interaction with
Sp1 and COUP-TF (18). CTIP2 promotes HIV-1 tran-
scriptional silencing by recruiting the histone deacetylase
1 (HDAC1), HDAC2, the histone methyltransferase
SUV39H1 as well as the histone demethylase Lysine (K)-
speciﬁc demethylase 1 (LSD1) to theHIV promoter, which
subsequently establish a heterochromatin environment
(19–21).
The non-histone chromatin protein High mobility
group AT-hook 1 (HMGA1) is able to interact with
the loop2 substructure of 7SK RNA (22,23), which is
also the interface between 7SK and CTIP2 (11).
HMGA1 can associate with P-TEFb–bound 7SK
RNA, and recent studies support a model of 7SK
RNA-mediated recruitment of P-TEFb to the promoters
of selected cellular target genes via HMGA1 (24). While
we have recently identiﬁed HMGA1 to speciﬁcally
interact with the HIV-1 transactivating response
element (TAR), thereby repressing viral transcription
likely by competing with cellular and viral activators
(25), also the Sp1 binding site within the HIV-1 core
promoter has been shown to be essential for efﬁcient
viral transcription (8). Besides the fact that HMGA1
interacts with a large variety of transcription factors,
among those NF-kB and Sp1 (26), there are several
high- and low-afﬁnity binding sites for HMGA1 within
the HIV-1 core promoter (27), pointing at additional
roles of HMGA1 during HIV transcription.
Thus, we here set out to investigate whether HMGA1 is
involved in the recruitment of CTIP2-inactivated P-TEFb
to HIV-1 and cellular target promoters to regulate viral
and endogenous gene expression.
MATERIALS AND METHODS
Cell culture and transfections
HEK293, human microglial cells [CMEH3 cell line, cor-
responding to clone 3 described by Janabi et al. (28)] and
HIV-latently infected CHME-5 cells (29) were cultured as
described previously (11). Transfections were performed
using FugeneHD (Roche) or JetPrime (Polyplus) accord-
ing to the manufacturer’s instructions. The plasmids used
for 7SK knock-down (24), 7SK overexpression (23),
dnCdk9 expression (24), HMGA1 knock-down/
overexpression (22,24) and CTIP2 knock-down/
overexpression (19) have been described previously. Cell
viability was tested 48 h after transfection by measuring
the mitochondrial dehydrogenase activity using the Water
soluble tetrazolium (WST)-1 reduction assay (Roche) fol-
lowing manufacturer’s instructions. The viability of cells
transfected with control short hairpin (sh)RNA was arbi-
trarily set to 100%.
Immunoprecipitation assays and western blot analyses
Immunoprecipitations of HMGA1-FLAG fusions were
performed from nuclear extracts of transiently transfected
HEK293 cells using M2 anti-FLAG agarose (Sigma)
as recommended by the manufacturer. Endogenous
HMGA1 was immunopuriﬁed from nuclear extracts
using a speciﬁc anti-HMGA1 antibody (Abcam).
Immunopuriﬁcations with boiled anti-HMGA1 IgG were
used as a control. Sodium dodecyl sulphate-polyacryl-
amide gel electrophoresis (SDS-PAGE) and blotting
were performed as described previously (22). Antibodies
used in western blot analyses were M2 anti-FLAG
antibody (Sigma), anti-HMGA1 antibody (Abcam), anti-
CTIP2 antibody (Abcam), anti-Cdk9 antibody (Pierce),
anti-CycT1 antibody (Proteintech), anti-HEXIM1
antibody (Proteintech) and anti-LARP7 antibody
(Proteintech) with the corresponding secondary horserad-
ish peroxidase-coupled antibodies (Sigma) as recom-
mended by the manufacturer.
Quantitative reverse transcriptase-polymerase chain
reaction
Quantitative reverse transcriptase-polymerase chain
reaction (qRT-PCR) analyses were performed as
described previously (22,30). Primers to amplify 7SK
RNA were 50-CAT CCC CGA TAG AGG AGG AC-30
(sense) and 50-GCC TCA TTT GGA TGT GTC TG-30
(antisense). U6 RNA primers were 50-CGC TTC GGC
AGC ACA TAT AC-30 (sense) and 50-AAA ATA TGG
AAC GCT TCA CGA-30 (antisense). HIV transcripts
were detected with primers directed against the TAR
region: 50-GTT AGA CCA GAT CTG AGC CT-30
(sense) and 50-GTG GGT TCC CTA GTT AGC CA-30
(antisense). b-Actin mRNA primers were 50-GTC GAC
AAC GGC TCC GGC-30 (sense) and 50-GGT GTG
GTG CCA GAT TTT CT-30 (antisense).
HIV-1 promoter-driven reporter assays
On shRNA-mediated knock-down or overexpression of
HMGA1 and/or CTIP2, CMEH3 microglial cells were
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transfected with a HIV-1 Long terminal repeat (LTR)-
driven luciferase reporter in the presence or in the
absence of HIV-1 Tat-FLAG. The efﬁciencies of the
used constructs have been previously validated (19,20).
After 48 h, cells were harvested and luciferase activity
was quantiﬁed using the Dual Luciferase Reporter
Assay System and GloMax-96 Microplate
Luminometer (Promega) according to the manufacturers’
instructions. A renilla reporter was used for normaliza-
tion. To assess the relative viral expression, a HIV-1
LTR-driven reporter containing the full viral genome
fused to the luciferase reporter was used.
For transcription assays with integrated virus, HIV-
latently infected CHME-5 cells (29) were transfected
with CTIP2- (19) and/or HMGA1-targeting shRNA
vectors (22) in comparison with a non-targeting shRNA
vector as a control (22) and HIV gene expression was
quantiﬁed 48 h after transfection by quantitative RT-
PCR (29).
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were per-
formed as described previously (31). HEK293 cells were
transfected with the HIV-1 LTR-driven luciferase
reporter, FLAG-CTIP2, HMGA1-targeting shRNA or
non-targeting control shRNA constructs. pcDNA3
vector (Invitrogen) has been used as control. ChIP
assays were performed 48 h after transfection according
to the Millipore protocol. Cells were cross-linked with
1% formaldehyde for 10min at 37C. After quenching
of formaldehyde with 125mM glycine for 5min at room
temperature, the ﬁxed cells were washed with 1 PBS,
harvested and centrifuged at 1300 rpm at 4C for 5min.
The cell pellet was resuspended in lysis buffer (0.1% SDS,
50mM HEPES, pH 7.9, 140mM NaCl, 1mM EDTA, 1%
Triton X-100, 0.1% Na-deoxycholate) to a ﬁnal concen-
tration of 4 106 cells/400 ml in presence of protease in-
hibitors (1mM phenylmethylsulfonyl ﬂuoride (PMSF),
1 protease inhibitor coctail (PIC)), incubated on ice for
10min and sonicated with a Bioruptor sonicator
(Diagenode, Philadephia, PA, USA; 30 s on–30 s off
cycles for 30min at high intensity). The solubilized chro-
matin was clariﬁed by centrifugation for 10min at
13 000 rpm at 4C and the supernatant was diluted 5-
fold in ChIP dilution buffer (16.7mM Tris–HCl at pH
8.1, 1.2mM EDTA, 167mM NaCl, 0.01% SDS and
1.1% Triton X-100) for immunoprecipitation. The
primary antibodies used for ChIP were anti-CTIP2
(bethyl), anti-Cdk9 (Santa Cruz), anti-Cyclin T1 (Santa
Cruz) and anti-Hexim-1 (Abcam). Immunocomplexes
were collected by rotation for 2 h at 4C with 50 ml of
protein A sepharose preblocked with yeast tRNA and
BSA. The beads were washed sequentially for 4min at
4C with rotation, once each with low salt buffer
(20mM Tris–HCl at pH 8.1, 2mM EDTA, 150mM
NaCl, 0.1% SDS and 1% Triton X-100), high salt
buffer (20mM Tris–HCl at pH 8.1, 2mM EDTA,
500mM NaCl, 0.1% SDS and 1% Triton X-100), LiCl
buffer (10mM Tris–HCl at pH 8.1, 1mM EDTA,
0.25M LiCl, 1% NP40 and 1% Deoxycholate) and
twice with Tris-EDTA (TE) buffer (10mM Tris–HCl at
pH 8.0, 1mM EDTA). Immunocomplexes were eluted
twice with 250 ml of elution buffer (1% SDS, 0.1M
NaHCO3) for 15min at room temperature. Eluates and
input chromatin were heated to 65C overnight in the
presence of 0.2M NaCl to reverse formaldehyde cross-
linking, treated with 2 ml of proteinase K (10mg/ml),
10 ml of 0.5M EDTA and 20ml of 1M Tris–HCl (pH
6.5) for 1 h at 45C. DNA was phenol/chloroform ex-
tracted and precipitated with ethanol plus glycogen as
carrier. Immunoprecipitated DNA was subjected to real-
time PCR quantiﬁcation on an ABI Prism 7000
Ligthcycler using the Power SYBR Green kit (Applied
Biosystems). The speciﬁcity of the enrichment has been
controlled by ampliﬁcation of the GAPDH gene. The fol-
lowing primer sequences were used: HIV-1 promoter: 50-
CAG CTG CTT TTG CCT GTA CTG-30 (forward) and
50-TCC ACA CTG ACT AAA AGG GTC TGA-30
(reverse); luciferase gene: 50-CCG TGA TGG AAT
GGA ACA AC-30 (forward) and 50-CAT AGA ACT
GCC TGC GTC A-30 (reverse); Epithelial stromal
interaction 1 (EPSTI1) promoter: 50-CGT GGC TGA
TCC CAG TTA TT-30 (forward) and 50-CCA GAG
AAC TTC CCC ACG TA-30 (reverse); Poly [ADP-
ribose] polymerase 12 (PARP12) promoter: 50-TAC CTC
CCA GGT AGG GTT CC-30 (forward) and 50-GCC CTT
TGA GGA GGT AAT CC-30 (reverse).
Gene expression proﬁling and data analysis
Total RNA from transfected microglial cells was prepared
using the RNeasy Midi Kit (Qiagen) as recommended by
the manufacturer. The RNA was labelled using the
Illumina TotalPrepTM RNA Ampliﬁcation Kit
(Ambion) according to the manufacturer’s instructions.
For microarray analyses, hybridization and detection
were performed following the protocols supplied by
Illumina using the HumanHT-12 v4 Expression
BeadChip Kit and an iScan system (both Illumina). The
raw data were quality controlled (32), NeoNORM
normalized using k=0.2 (33) and analyzed as outlined
in (34,35). For subtraction proﬁling we used the CDS stat-
istical test (36) with a positive false discovery rate correc-
tion where appropriate. Canonical pathway enrichment
studies were performed using Ingenuity Pathway
Analysis software (Ingenuity Systems) as recommended
by the manufacturer. Transcriptome data were deposited
in the public database MACE (http://mace.ihes.fr) using
Accession Nos.: 3037572262 (CTIP2 knock-down),
2166467750 (CTIP2 overexpression), 3164892326
(HMGA1 knock-down), 2365090982 (HMGA1
overexpression), 2401152166 (7SK knock-down),
3197764774 (7SK overexpression) and 2967448742
(dnCdk9 expression).
RESULTS
HMGA1 interacts with CTIP2 in an RNA-independent
fashion
HMGA1 interacts with the 7SK/P-TEFb snRNP via the
loop2 substructure of the RNA (22–24), while CTIP2,
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besides interacting with the same part of 7SK, is also able
to directly bind HEXIM1 in an RNA-independent
manner (11). Thus, we tested ﬁrst, whether HMGA1 and
CTIP2 can interact and whether 7SK RNA can mediate
an interaction between HMGA1, CTIP2 and P-TEFb.
For that we performed immunopuriﬁcations of
HMGA1-FLAG from transiently transfected HEK293
cells in the presence and absence of RNase A and subse-
quently monitored the amounts of co-puriﬁed endogenous
CTIP2 (Figure 1A). A signiﬁcant amount of CTIP2 co-
precipitates with HMGA1 in an RNase-resistant fashion,
while a portion of the inactive P-TEFb snRNP, namely,
Cdk9, CycT1 and HEXIM1 as well as the stably 7SK-
associated protein LARP7 associates with HMGA1 via
RNA (Figure 1A). As CTIP2 interacts with HMGA1 in
an RNA-independent manner, it adds to a number of pre-
viously reported HMGA1-interacting partners, such as
AP1, NF-kB, c-Jun, PU.1 or Sp1 (26,37–39), suggesting
that HMGA1 might be involved in the recruitment of
CTIP2 and CTIP2-associated enzymes. To verify the as-
sociation of the endogenously expressed proteins, we per-
formed an immunopuriﬁcation of endogenous HMGA1
from microglial cells using a speciﬁc anti-HMGA1
antibody and monitored the precipitation step for
endogenous CTIP2 (Figure 1B). Also, endogenous
CTIP2 co-puriﬁed with endogenous HMGA1.
HMGA1 and CTIP2 cooperatively repress
P-TEFb–dependent gene expression
Our hitherto results allow for a functional connection of
HMGA1 and CTIP2, which might affect the expression of
P-TEFb target genes. To test this hypothesis, we used
global gene expression proﬁling to identify and compare
CTIP2, HMGA1 and P-TEFb target genes in microglial
cells.
To identify genes, whose expression is affected by
CTIP2 and HMGA1, the expression of endogenous
CTIP2 and HMGA1 was knocked down using speciﬁc
shRNAs (Figure 2A and B), before gene expression
changes were assessed using microarray analyses. On
CTIP2 knock-down, 4680 genes were regulated, of which
3525 genes (75%) were up-regulated and 1155 (25%)
down-regulated (Supplementary Figure S1A). Thus,
CTIP2 predominantly represses target gene expression,
which is in line with previously reported roles of CTIP2
(8,9). The HMGA1 knock-down resulted in the regulation
of 1791 genes, of which 782 genes (44%) were up- and
1009 genes (56%) were down-regulated (Supplementary
Figure S1A). Comparing the HMGA1 and the CTIP2
target genes, we observe a common subset of 1394
genes being signiﬁcantly regulated in both conditions
(Figure 2C, left panel). The expression of 1391 genes
(99.71%) among the common subset is highly positively
correlated (R ¼ 0:92) when comparing CTIP2 knock-
down and HMGA1 knock-down (Figure 2C, right
panel). Including the full target sets of CTIP2 or
HMGA1 does not affect the strong positive correlation
(R ¼ 0:88 and R ¼ 0:91, respectively), uncovering that
CTIP2 and HMGA1 affect gene expression in the same
manner and that the CTIP2 and HMGA1 target genes are
virtually identical in microglial cells (Figure 2C, right
panel). To identify 7SK-dependent P-TEFb target genes,
we performed transcriptome proﬁling of microglial
cells on 7SK RNA overexpression (Figure 2D) and
overexpression of a dominant negative (dn), kinase-dead
version of Cdk9 fused to a HA-tag (Figure 2E). Because
7SK RNA is a negative regulator of P-TEFb, its
overexpression is expected to shift the equilibrium of
P-TEFb towards its inactive state as it is the case for the
overexpression of dnCdk9. 7SK RNA overexpression
led to a differential expression of 3346 genes, of which
962 genes (29%) showed an elevated expression and
2384 genes (71%) exhibited a diminished expression
(Supplementary Figure S1A). The expression of dnCdk9
resulted in the differential expression of 6291 genes,
among those, 2667 genes (42%) being up- and 3624
genes (58%) being down-regulated (Supplementary
Figure S1A). The target genes of 7SK overexpression
and dnCdk9 expression show a statistically highly signiﬁ-
cant (P < 3:49 10324) common subset of 2623 genes
(Figure 2F, left panel), whose expression changes are
highly positively correlated (R ¼ 0:90) when comparing
7SK overexpression and dnCdk9 expression (Figure 2F,
right panel). Notably, the expression of 1872 genes (71%
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Figure 1. HMGA1 interacts with CTIP2 in an RNA-independent
fashion, while the association with inactive P-TEFb is RNase-sensitive.
(A) Immunopuriﬁcation of HMGA1-FLAG from transiently trans-
fected HEK293 cells in the presence or the absence of RNase A.
Input and precipitation steps were monitored for endogenous CTIP2,
Cdk9, CycT1, HEXIM1 and the 7SK-associated LARP7 in western
blot analyses. Mock-transfected cells were used as a control.
(B) Immunopuriﬁcation of endogenous HMGA1 from microglial cells
using a speciﬁc anti-HMGA1 antibody. Input and precipitation steps
were monitored for endogenous HMGA1 and CTIP2. An immunopur-
iﬁcation with boiled anti-HMGA1 IgG was used as a control.
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of the common subset) is down-regulated in both condi-
tions, which is in concordance with the role of 7SK RNA
as a negative P-TEFb regulator. However, to work on a
reliable set of 7SK target genes, we included a condition of
shRNA-mediated 7SK knock-down (Figure 2G). Ideally,
P-TEFb target genes, which are down-regulated by the
overexpression of 7SK RNA, should be up-regulated by
a 7SK RNA knock-down. Such a knock-down led to a
statistically signiﬁcant (P < 0:01) regulation of 3826 genes,
of which 3354 genes (88%) were up- and 472 genes (12%)
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Figure 2. HMGA1 and CTIP2 repress the expression of 7SK-dependent P-TEFb target genes. (A) shRNA-mediated knock-down of CTIP2 in micro-
glial cells. CTIP2 levels were monitored in western blot analyses and b-actin was used as a control (upper panel). Cell viability on shRNA-mediated
knock-down was measured by MTT test (lower panel). n.s., not statistically signiﬁcant in a students t-test. (B) shRNA-mediated knock-down of
HMGA1 in microglial cells. HMGA1 amounts were quantiﬁed by western blot analyses, and b-actin was used as a housekeeping gene (upper
panel). Cell viability was measured as in (A) (lower panel). (C) Venn diagram (left panel) and scatter plot (right panel) of the CTIP2-target genes
(P < 0:01, blue), the HMGA1-target genes (P < 0:05, red) and the common subset (purple). The gene numbers of each set, the hypergeometric
distribution P-value as well as the Pearson correlation coefﬁcients for all three subsets and the fractions located in each quadrant of the scatter plot
are indicated. (D) Overexpression of 7SK RNA in microglial cells. RNA amounts were monitored by ethidium bromide staining on agarose gel
electrophoresis, and U6 RNA was used as a control. (E) Overexpression of a HA-tagged, dominant negative (dn) version of Cdk9 in microglial
cells. dnCdk9 expression was monitored in western blot analyses using anti-HA and anti-Cdk9 antibodies. (F) as in (C), but for the target genes of
dnCdk9 (yellow) and 7SK RNA overexpression (green). (G) shRNA-mediated knock-down of 7SK RNA in microglial cells. RNA amounts were
monitored as in (D). Cell viability was measured as in (A). (H) Identiﬁcation of 7SK-dependent P-TEFb targets as genes, whose expression is
concomitantly regulated on dnCdk9 expression (yellow), 7SK RNA overexpression (green) and 7SK RNA knock-down (turquoise). The number of
genes is plotted on the x-axis and the log2-fold change in each condition is plotted on the y-axis. Genes are plotted in descending order based on their
expression changes on dnCdk9 expression. (I) Scatter plot comparing the expression changes of the P-TEFb targets identiﬁed in (H) on 7SK knock-down
with their expression changes on CTIP2 knock-down. Genes statistically signiﬁcantly regulated on CTIP2 knock-down are coloured in blue and the
Pearson correlation coefﬁcient is indicated. (J) Scatter plot comparing the expression changes of the P-TEFb targets identiﬁed in (H) on 7SK knock-
down with their expression changes on HMGA1 knock-down. Genes statistically signiﬁcantly regulated on HMGA1 knock-down are coloured in red.
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were down-regulated (Supplementary Figure S1A). We
deﬁned those genes, whose expression was concordingly
affected by 7SK overexpression, 7SK knock-down and
dnCdk9 expression in a statistically signiﬁcant manner
(P < 0:01), meaning, for example, genes whose expression
was down-regulated by 7SK and dnCdk9 overexpression
and up-regulated by 7SK knock-down, as 7SK-dependent
P-TEFb target genes (Figure 2H). Among those, 264 genes
(96%) are activated and 10 genes (4%) are repressed by
P-TEFb, which is in line with the general gene-activating
function of P-TEFb. We performed canonical pathway
enrichment studies to identify those cellular pathways,
which are affected most in each single condition, revealing
that various pathways are affected in several conditions
simultaneously (Supplementary Figure S1B–E).
To assess the role of CTIP2 and HMGA1 during the ex-
pression of these 7SK-dependent P-TEFb target genes, we
compared their expression changes on 7SK knock-down
with their differential expression on CTIP2 (Figure 2I)
and HMGA1 knock-down (Figure 2J). In both cases the
gene expression changes are highly positively correlated
(R ¼ 0:80 for CTIP2 and R ¼ 0:93 for HMGA1),
showing that both CTIP2 and HMGA1 concomitantly
repress the expression of 7SK-dependent P-TEFb target
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genes. Network analyses based on these genes place the
inactive P-TEFb snRNP upstream of our observed target
genes, conﬁrming our experimental approach (Figure 3A).
To conﬁrm that our observations were due to a repressive
effect of CTIP2 and HMGA1 on 7SK-dependent P-TEFb
target genes, we added global gene expression analyses of
CTIP2 and HMGA1 overexpressing microglial cells
(Figure 3B and D). The majority of the 7SK-dependent
P-TEFb targets, whose expression was enhanced on
CTIP2 and HMGA1 knock-down, was repressed on
CTIP2 and HMGA1 overexpression (Figure 3C and E).
HMGA1 is involved in the recruitment of CTIP2 and
CTIP2-repressed P-TEFb to cellular gene promoters
Our ﬁndings support a model in which HMGA1 is
involved in the recruitment of the P-TEFb repressor
CTIP2 and/or the CTIP2-repressed P-TEFb snRNP to
target promoters, as HMGA1 interacts with a large
variety of transcription factors and also with speciﬁc
DNA target sites.
To answer this question, we randomly chose PARP12
and EPSTI1 as two 7SK-dependent P-TEFb target genes,
whose expression is repressed by CTIP2 as well as
HMGA1 (Figure 3F). We performed ChIP analyses
from HEK293 cells overexpressing CTIP2 to investigate
the impact of CTIP2 levels on the recruitment of the
P-TEFb snRNP to the gene promoters (Figure 3G and
H). The overexpressed CTIP2 itself located at the
PARP12 and the EPSTI1 promoter and resulted in an
increased recruitment of the inactive P-TEFb snRNP—
Cdk9, CycT1 and HEXIM1 (Figure 3G and H, black
bars). A simultaneous knock-down of HMGA1 led to a
signiﬁcant loss of the recruitment of CTIP2 and the
inactive P-TEFb snRNP (Figure 3G and H, white bars),
supporting a role of HMGA1 during the recruitment of
CTIP2-inactivated P-TEFb.
HMGA1 and CTIP2 synergistically repress HIV-1
promoter activity
HIV-1 gene expression critically depends on P-TEFb
function. Thus, we set out to investigate the impact of
CTIP2 and HMGA1 on HIV-1 transcription.
We performed HIV-1 promoter-driven luciferase
reporter assays in microglial cells on shRNA-mediated
knock-down of HMGA1 and/or CTIP2 both in the
presence and in the absence of Tat (Figure 4). In the
latter case, the HMGA1 knock-down alone results in an
increase of HIV-1 promoter activity, which is comparable
with that on CTIP2 knock-down (Figure 4A). The simul-
taneous knock-down of both proteins results in a boost of
promoter activity, which goes beyond an additional effect
of each single knock-down, indicating a synergistic
pathway being involved (Figure 4A). To conﬁrm our
ﬁndings, which were obtained using a non-integrated
reporter plasmid, in the context of an integrated
provirus, we knocked down CTIP2, HMGA1 or both
proteins simultaneously in HIV-latently infected CHME-
5 cells (29) and subsequently measured viral transcription
by qRT-PCR (Figure 4B). Also in the context of a latently
integrated provirus, a knock-down of CTIP2 and
HMGA1 results in a statistically signiﬁcant induction of
viral transcription, which is boosted in a synergistic
manner when both proteins are knocked down simultan-
eously (Figure 4B). Also in the presence of Tat the knock-
down of HMGA1 or CTIP2 leads to an increased HIV-1
promoter activity, which is boosted when both proteins
are knocked down simultaneously (Figure 4C). Next, we
quantiﬁed HIV-1 expression on modulations of CTIP2
and HMGA1 levels in microglial cells. As expected, the
concomitant knock-downs of CTIP2 and HMGA1 syner-
gistically stimulate the expression of the pNL4.3
delta envelope (ENV) luciferase provirus, in which the
ENV gene has been replaced by the luciferase reporter
(Figure 4D). Consistent with these ﬁndings, the
overexpression of both proteins collaborates in silencing
HIV-1 expression (Figure 4E).
HMGA1 recruits CTIP2-inactivated P-TEFb to the
HIV-1 promoter
As it is the case for host cellular P-TEFb target genes, also
the repressive synergistic cooperativity of CTIP2 and
HMGA1 in the case of HIV-1 transcription might be a
consequence of a HMGA1-mediated recruitment of the
CTIP2-inactivated 7SK/P-TEFb snRNP to the HIV
promoter.
HMGA1 localizes at the HIV-1 core promoter, as
veriﬁed by ChIP experiments from HEK293 cells on
overexpression of HMGA1-FLAG or knock-down of en-
dogenous HMGA1 (Figure 4F). To investigate the impact
of CTIP2 levels on the recruitment of the P-TEFb snRNP
to the HIV promoter, we performed ChIP analyses from
HEK293 cells carrying the HIV-1 promoter-driven
luciferase reporter construct and overexpressing CTIP2
(Figure 4G). As it was the case for the host cellular
genes PARP12 and EPSTI1, the overexpression of
CTIP2 increased the recruitment of the inactive P-TEFb
snRNP to the HIV-1 core promoter (Figure 4G). Also
in the case of the HIV-1 promoter, the simultaneous
knock-down of HMGA1 led to a signiﬁcant loss of the
recruitment of CTIP2 and the inactive P-TEFb snRNP
(Figure 4G, upper panel). The luciferase gene downstream
of the HIV-1 promoter showed neither a signiﬁcant en-
richment of the inactive P-TEFb snRNP nor a signiﬁcant
impact of the HMGA1 knock-down (Figure 4G, lower
panel). Together, these ﬁndings support a model, in
which HMGA1 not only recruits the CTIP2-repressed
P-TEFb snRNP to cellular gene promoters, but also to
the HIV-1 core promoter.
DISCUSSION
We here establish a global cooperativity of HMGA1 and
CTIP2 in terms of gene expression regulation, including
the regulation of 7SK-dependent P-TEFb target genes.
While CTIP2 contributes to Cdk9 inactivation as a part
of the inactive 7SK/P-TEFb snRNP in microglial cells
(11), HMGA1 has been previously proposed to be
involved in the recruitment of P-TEFb to selected target
promoters (24). The inactive 7SK/P-TEFb snRNP
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has been detected at the HIV-1 core promoter in a Sp1-
dependent fashion (8). A recent study has provided
evidence for the 7SK/P-TEFb snRNP also associating
with active endogenous gene promoters in a genome-
wide manner (40). This study suggests an involvement of
the serine arginine-rich (SR) protein SRSF2 (SC35) in the
recruitment of activated P-TEFb to paused RNA Pol II
via an interaction with the nascent transcript, a
mechanism similar to the Tat/TAR interaction in the
case of HIV. Our ﬁndings suggest that HMGA1 is import-
ant for the repressive function of CTIP2 and support a
model in which HMGA1 mediates the recruitment of
CTIP2-inactivated P-TEFb to cellular and viral gene pro-
moters, where SRSF2 or HIV-1 Tat are subsequently
needed for P-TEFb activation (Figure 4H). Notably,
HMGA1 has been previously found to co-localize with
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SC35 at hypoxic conditions, which might provide plasti-
city between the recruitment of inactive P-TEFb to the
promoter and P-TEFb activation under stress conditions
(41). However, the strong global synergy between
HMGA1 and CTIP2 may go beyond a cooperative
P-TEFb pathway and may include, for instance, also a
HMGA1-mediated recruitment of CTIP2 and CTIP2-
associated chromatin-modifying enzymes. Also, the re-
cruitment of the CTIP2-binding histone deacetylases
HDAC1, HDAC2 and the histone demethylase LSD1
have been shown to depend on Sp1 (19,20). Because we
have shown the latter complex to be distinct from the
inactive CTIP2/7SK/P-TEFb snRNP (11), both recruit-
ment pathways would likely be mutually exclusive.
Taken together, the HMGA1-mediated recruitment of
CTIP2-repressed P-TEFb not only affects endogenous
gene expression in microglial cells but, moreover,
also modulates the expression of the HIV-1 genome.
The identiﬁcation of host-cellular factors involved in
HIV-1 silencing, as accomplished here, contributes to a
more detailed understanding of how viral latency is estab-
lished and maintained and thus may open ways to novel
therapeutic approaches for ﬁghting HIV infection
(42,43,44).
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